[go: up one dir, main page]

DE602004011055D1 - PREOPERATIVE TREATMENT OF POSTOPERATIVE PAIN - Google Patents

PREOPERATIVE TREATMENT OF POSTOPERATIVE PAIN

Info

Publication number
DE602004011055D1
DE602004011055D1 DE602004011055T DE602004011055T DE602004011055D1 DE 602004011055 D1 DE602004011055 D1 DE 602004011055D1 DE 602004011055 T DE602004011055 T DE 602004011055T DE 602004011055 T DE602004011055 T DE 602004011055T DE 602004011055 D1 DE602004011055 D1 DE 602004011055D1
Authority
DE
Germany
Prior art keywords
postoperative pain
preoperative treatment
surgery
dosage form
patient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602004011055T
Other languages
German (de)
Other versions
DE602004011055T2 (en
Inventor
Bruce E Reidenberg
Daniel A Spyker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Euro Celtique SA
Original Assignee
Euro Celtique SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro Celtique SA filed Critical Euro Celtique SA
Publication of DE602004011055D1 publication Critical patent/DE602004011055D1/en
Application granted granted Critical
Publication of DE602004011055T2 publication Critical patent/DE602004011055T2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Medicinal Preparation (AREA)
  • Prostheses (AREA)
  • Processing Of Meat And Fish (AREA)

Abstract

A method of treating postoperative pain in a patient undergoing a surgery is described. The method is based on preoperative administration of a buprenorphine-containing transdermal dosage form. The dosage form can be administered to the patient, for example, 1-4 days prior to surgery. Alternative embodiments of the invention include subsequent transdermal dosage forms to treat the postoperative pain.
DE602004011055T 2003-07-25 2004-07-26 PREOPERATIVE TREATMENT OF POSTOPERATIVE PAIN Expired - Lifetime DE602004011055T2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US49036303P 2003-07-25 2003-07-25
US490363P 2003-07-25
PCT/US2004/024009 WO2005011578A2 (en) 2003-07-25 2004-07-26 Preoperative treatment of post operative pain

Publications (2)

Publication Number Publication Date
DE602004011055D1 true DE602004011055D1 (en) 2008-02-14
DE602004011055T2 DE602004011055T2 (en) 2008-12-18

Family

ID=34115386

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004011055T Expired - Lifetime DE602004011055T2 (en) 2003-07-25 2004-07-26 PREOPERATIVE TREATMENT OF POSTOPERATIVE PAIN

Country Status (27)

Country Link
US (3) US20080026042A1 (en)
EP (1) EP1638492B1 (en)
JP (1) JP5632573B2 (en)
KR (4) KR20060054346A (en)
CN (1) CN1829489B (en)
AT (1) ATE382354T1 (en)
AU (1) AU2004261181B2 (en)
BR (1) BRPI0412924A (en)
CA (1) CA2529983C (en)
CY (1) CY1107352T1 (en)
DE (1) DE602004011055T2 (en)
DK (1) DK1638492T3 (en)
EA (1) EA009213B1 (en)
ES (1) ES2299871T3 (en)
GE (1) GEP201606538B (en)
HR (1) HRP20080146T3 (en)
IL (1) IL173345A (en)
IS (1) IS8186A (en)
MA (1) MA28005A1 (en)
MX (1) MXPA06000990A (en)
NO (1) NO326636B1 (en)
NZ (1) NZ594154A (en)
PL (1) PL1638492T3 (en)
PT (1) PT1638492E (en)
UA (1) UA81689C2 (en)
WO (1) WO2005011578A2 (en)
ZA (1) ZA200510071B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5968547A (en) 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
DE10361306A1 (en) * 2003-12-24 2005-07-28 Lts Lohmann Therapie-Systeme Ag Wound dressing and wound dressing with a vasoconstrictive ingredient, and manufacturing method therefor
JP2011251944A (en) * 2010-06-02 2011-12-15 Kansai Medical Univ Analgesic preparation for embedding
DE102010024105A1 (en) * 2010-06-17 2011-12-22 Grünenthal GmbH Transdermal administration of memantine
EP2611445B1 (en) * 2010-09-03 2018-08-15 Zoetis Belgium S.A. High dose buprenorphine compositions and use as analgesic
RU2459640C2 (en) * 2010-10-26 2012-08-27 Государственное учреждение здравоохранения "Воронежская областная клиническая больница № 1" Method for postoperative anaesthesia in patients operated under spinal anaesthesia
RU2487734C1 (en) * 2011-11-17 2013-07-20 Анатолий Анатольевич Лаврентьев Method of postoperative anaesthesia
RU178867U1 (en) * 2016-05-04 2018-04-20 Общество с ограниченной ответственностью Научно-производственное предприятие "НОК" Vacuum micro-size crystallization cell
RU2649961C1 (en) * 2017-02-28 2018-04-05 Федеральное государственное бюджетное научное учреждение "Томский национальный исследовательский медицинский центр Российской академии наук" (Томский НИМЦ) Method of anesthesia after carrying out cesarean section operations in patients with excessive body mass
AU2023338560A1 (en) * 2022-09-09 2025-04-24 The Regents Of The University Of California Compositions for preventing transition from acute to chronic pain

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4119713A (en) * 1977-02-09 1978-10-10 Sam Carosio Analgesic and anti-inflammatory composition
US4806341A (en) * 1985-02-25 1989-02-21 Rutgers, The State University Of New Jersey Transdermal absorption dosage unit for narcotic analgesics and antagonists and process for administration
US5026556A (en) * 1988-11-10 1991-06-25 Norwich Eaton Pharmaceuticals, Inc. Compositions for the transdermal delivery of pharmaceutical actives
US5240711A (en) * 1989-11-29 1993-08-31 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Transdermal therapeutic system comprising as active component buprenorphine
ES2081477T3 (en) * 1990-04-24 1996-03-16 Teijin Ltd PATCH.
US5069909A (en) * 1990-06-20 1991-12-03 Cygnus Therapeutic Systems Transdermal administration of buprenorphine
SE9003665D0 (en) * 1990-11-16 1990-11-16 Kabivitrum Ab MORPHINE PRODRUGS
JP2669951B2 (en) * 1991-03-28 1997-10-29 雍憲 森本 Transdermal composition containing narcotic analgesic
US5613958A (en) * 1993-05-12 1997-03-25 Pp Holdings Inc. Transdermal delivery systems for the modulated administration of drugs
CA2174803C (en) * 1996-04-23 2000-07-11 Jonathan P. Wong Use of liposome encapsulated ciprofloxacin as an immunotherapeutic drug
JPH1036265A (en) * 1996-07-19 1998-02-10 Nitto Denko Corp Buprenorphine transdermal preparation
US5968547A (en) * 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
US5942530A (en) * 1997-08-28 1999-08-24 Eli Lilly And Company Method for treating pain
KR100383252B1 (en) * 1998-12-17 2003-07-16 주식회사 삼양사 Transdermal Dosage Compositions Containing Buprenoline and Patches Comprising the Same
DE19901085C2 (en) * 1999-01-14 2003-12-18 Lohmann Therapie Syst Lts Transdermal therapeutic system with a self-adhesive matrix containing organic acid addition salts of morphine or morphine type alkaloids
JP4659943B2 (en) * 2000-02-25 2011-03-30 帝三製薬株式会社 Patch containing buprenorphine hydrochloride
AU2001262683A1 (en) * 2000-06-02 2001-12-17 Teijin Limited Buprenorphine-containing patch
GB0026137D0 (en) * 2000-10-25 2000-12-13 Euro Celtique Sa Transdermal dosage form
US20020106407A1 (en) * 2000-12-11 2002-08-08 Dennis Coleman Method and apparatus for treating breakthrough pain
ATE459317T1 (en) * 2001-04-23 2010-03-15 Euro Celtique Sa DISPOSAL SYSTEM FOR TRANSDERMAL DOSAGE FORMS
EP2316439B1 (en) * 2001-05-01 2015-06-17 Euro-Celtique S.A. Abuse resistant opioid containing transdermal systems
ATE456097T1 (en) * 2001-05-22 2010-02-15 Euro Celtique Sa CONTAINER AND METHOD FOR DISPENSING TRANSDERMAL DOSAGE FORMS
AU2003297073A1 (en) * 2002-12-13 2004-07-09 Euro-Celtique S.A. Transdermal buprenorphine dosage regimen for analgesia

Also Published As

Publication number Publication date
IL173345A (en) 2010-06-16
US20110002975A1 (en) 2011-01-06
CN1829489B (en) 2010-12-15
US20140221413A1 (en) 2014-08-07
JP5632573B2 (en) 2014-11-26
CN1829489A (en) 2006-09-06
ES2299871T3 (en) 2008-06-01
KR20080011248A (en) 2008-01-31
PL1638492T3 (en) 2008-06-30
KR20060054346A (en) 2006-05-22
HK1087907A1 (en) 2006-10-27
CY1107352T1 (en) 2012-12-19
AU2004261181B2 (en) 2009-08-06
NO326636B1 (en) 2009-01-26
EP1638492A2 (en) 2006-03-29
IL173345A0 (en) 2006-06-11
WO2005011578A3 (en) 2005-09-09
DK1638492T3 (en) 2008-05-13
GEP201606538B (en) 2016-09-12
UA81689C2 (en) 2008-01-25
CA2529983A1 (en) 2005-02-10
ZA200510071B (en) 2006-11-29
WO2005011578A2 (en) 2005-02-10
CA2529983C (en) 2010-07-20
EP1638492A4 (en) 2006-07-19
MA28005A1 (en) 2006-07-03
MXPA06000990A (en) 2006-04-11
EA009213B1 (en) 2007-12-28
NO20060912L (en) 2006-04-21
EP1638492B1 (en) 2008-01-02
NZ594154A (en) 2012-12-21
US20080026042A1 (en) 2008-01-31
PT1638492E (en) 2008-03-17
KR20090031961A (en) 2009-03-30
DE602004011055T2 (en) 2008-12-18
HRP20080146T3 (en) 2008-04-30
ATE382354T1 (en) 2008-01-15
AU2004261181A1 (en) 2005-02-10
BRPI0412924A (en) 2006-09-26
JP2007500133A (en) 2007-01-11
KR20120128715A (en) 2012-11-27
EA200600284A1 (en) 2006-06-30
IS8186A (en) 2005-12-19

Similar Documents

Publication Publication Date Title
CY1107352T1 (en) PRE-OPERATIVE THERAPEUTIC PURPOSE
DE60326354D1 (en) TRANSDERMAL DOSAGE FORM CONTAINING AN ACTIVE SUBSTANCE AND AN ANTAGONIST IN FREE BASE AND SALT FORM
ATE510542T1 (en) NORIBOGAIN USED TO TREAT PAIN AND DRUG DEPENDENCE
DE60222137D1 (en) SUGAR DERIVATIVES OF HYDROMORPHONE, DIHYDROMORPHINE AND DIHYDROISOMORPHINE, COMPOSITIONS THEREOF AND USE FOR THE PREVENTION AND TREATMENT OF PAIN
ATE375341T1 (en) THIADIAZOLYLPIPERAZINE DERIVATIVES SUITABLE FOR THE TREATMENT OR PREVENTION OF PAIN
CY1107262T1 (en) TREATMENT OF DEPENDENCE ADDITION
CY1108217T1 (en) METHOD OF ADMINISTRATION OF BUPRENORFINE FOR DEPARTMENT TREATMENT
BR0312597A (en) Drug Combinations for the Treatment of Neoplasms
ATE412646T1 (en) THERAPEUTIC AGENTS SUITABLE FOR THE TREATMENT OF PAIN
ATE422357T1 (en) USE OF ALLOPURINOL TO TREAT HYPERTENSION
WO2004039325A3 (en) Treatment of pain with jnk inhibitors
DE602004017888D1 (en) METHOD FOR THE TREATMENT OF ACUTE AND HYALURONIC ACIDIFICATION CAUSED BY EXCESSIVE INJURY AND STUPIDATION
ATE310509T1 (en) METHOD OF TREATING A PATIENT IN NEED OF ANALGESIA
ATE487480T1 (en) PERHEXILINE FOR THE TREATMENT OF CHRONIC HEART FAILURE
EA200600989A1 (en) APPLICATION OF GABOXADOL FOR THE TREATMENT OF CEREBELLS
DE69733321D1 (en) OLANZAPINE FOR THE TREATMENT OF DRUG ABUSE
DE60108775T8 (en) METHOD FOR THE TREATMENT OF STROKE
DE602004025001D1 (en) COMPOUNDS FOR THE TREATMENT OF NEUROPATHIC PAIN AND MIGRAINE
RU2006124481A (en) METHOD FOR TROPHIC ULCERS TREATMENT IN DIABETIC FOOT SYNDROME

Legal Events

Date Code Title Description
8364 No opposition during term of opposition